Literature DB >> 24258060

Enhancement of DC-mediated anti-leukemic immunity in vitro by WT1 antigen and CpG co-encapsulated in PLGA microparticles.

Liang Zhang1, Sun Zhao, Jinhong Duan, Yan Hu, Ning Gu, Haiyan Xu, Xian-Da Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24258060      PMCID： PMC4875406          DOI： 10.1007/s13238-013-3916-x

Source DB:  PubMed          Journal:  Protein Cell        ISSN： 1674-800X            Impact factor:   14.870


× No keyword cloud information.
  14 in total

1.  Long-term results of large prospective trials in childhood acute lymphoblastic leukemia.

Authors:  M Schrappe; B Camitta; C H Pui; T Eden; P Gaynon; G Gustafsson; G E Janka-Schaub; W Kamps; G Masera; S Sallan; M Tsuchida; E Vilmer
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

Review 2.  Dendritic cell immunotherapy: mapping the way.

Authors:  Carl G Figdor; I Jolanda M de Vries; W Joost Lesterhuis; Cornelis J M Melief
Journal:  Nat Med       Date:  2004-05       Impact factor: 53.440

3.  Immunology. Tumor immune evasion.

Authors:  Carlene L Zindl; David D Chaplin
Journal:  Science       Date:  2010-05-07       Impact factor: 47.728

4.  Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.

Authors:  Zhiping Zhang; Songsak Tongchusak; Yo Mizukami; Yoon Joong Kang; Tetsuya Ioji; Maki Touma; Bruce Reinhold; Derin B Keskin; Ellis L Reinherz; Tetsuro Sasada
Journal:  Biomaterials       Date:  2011-02-23       Impact factor: 12.479

5.  Biodegradable implants in fracture fixation: early results of treatment of fractures of the ankle.

Authors:  P Rokkanen; O Böstman; S Vainionpää; K Vihtonen; P Törmälä; J Laiho; J Kilpikari; M Tamminmäki
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

6.  Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells.

Authors:  Heidi A Schreiber; Jozsef Prechl; Hongquan Jiang; Alla Zozulya; Zsuzsanna Fabry; Ferencz Denes; Matyas Sandor
Journal:  J Immunol Methods       Date:  2010-02-26       Impact factor: 2.303

7.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.

Authors:  M Kovacsovics-Bankowski; K L Rock
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

8.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

9.  CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.

Authors:  C L Cooper; H L Davis; M L Morris; S M Efler; M Al Adhami; A M Krieg; D W Cameron; J Heathcote
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

10.  PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.

Authors:  Wenxue Ma; Mingshui Chen; Sharmeela Kaushal; Michele McElroy; Yu Zhang; Cengiz Ozkan; Michael Bouvet; Carol Kruse; Douglas Grotjahn; Thomas Ichim; Boris Minev
Journal:  Int J Nanomedicine       Date:  2012-03-15
View more
  1 in total

Review 1.  Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

Authors:  Liam J O'Brien; Camille Guillerey; Kristen J Radford
Journal:  Cancers (Basel)       Date:  2019-06-22       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.